Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Employer
- Stony Brook University
- Duke University
- Northeastern University
- Oak Ridge National Laboratory
- Zintellect
- Argonne
- CNRS
- Carnegie Mellon University
- ICN2
- NEW YORK UNIVERSITY ABU DHABI
- University of Florida
- University of Luxembourg
- Université Grenoble Alpes
- Aalborg Universitet
- Delft University of Technology (TU Delft); today published
- Georgia Institute of Technology
- INESC ID
- Institute of Nuclear Physics Polish Academy of Sciences
- Institute of Physical Chemistry, Polish Academy of Sciences
- Jerzy Haber Institute of Catalysis and Surface Chemistry, Polish Academy of Sciences
- KINGS COLLEGE LONDON
- KTH Royal Institute of Technology
- King's College London
- Luleå University of Technology
- MOHAMMED VI POLYTECHNIC UNIVERSITY
- NORCE
- Nature Careers
- New York University
- RIKEN
- The Ohio State University
- The University of Arizona
- UNIVERSITE ANGERS
- Umeå University
- Universidade de Coimbra
- Universitat Pompeu Fabra - Department / School of Engineering
- University of Central Florida
- University of Lille
- University of Oklahoma
- University of Oregon
- University of Oulu
- University of Oxford
- University of Oxford;
- University of Southern California
- University of Southern California (USC)
- University of Tuebingen
- Université de Caen Normandie
- Université de Limoges
- Virginia Tech
- 38 more »
- « less
-
Field
-
About Us The Jones Group are experts in pharmaceutical dermatology. They design of innovative pharmaceutical formulations and devices. They are interested in how therapeutic agents are released from
-
databases and retrieval-augmented generation (RAG) and integrate agentic AI systems to meet the demands of large-scale fine-tuning and inference. The postdoc will also work on design and implement agentic-AI
-
? Submit your application by Nov 30, 2025. Project description and working tasks This project proposes the implementation of a cognitive agent embodied in a humanoid robot which will collaborate with a human
-
sensing, AI/ML pipelines) into simulation and modeling platforms. Collaborate with GFSI partners and local to global stakeholders to contextualize and apply models in developing country settings. Lead and
-
the development of new radiopharmaceuticals, radiochemistry methodology and translation of lead agents for biomedical imaging. The incumbent will also participate in ongoing radiochemistry procedures for current
-
pharmaceutical dermatology. They design of innovative pharmaceutical formulations and devices. They are interested in how therapeutic agents are released from formulations and how they cross biological barriers
-
address scientific problems in pharmacology and medicine. Build and adapt AI-assisted tools (e.g., LLM-based agents) to support mechanistic model development and biomedical knowledge integration. Implement
-
primarily focus on one or more of these parts. The successful candidate will develop numerical tools and/or theoretical models to model and simulate the behavior of a group of agents capable of chemical
-
robots and competency in the Robot Operating System, and/or Physics Engine Simulators are preferred. The terms of employment are very competitive and include housing and educational subsidies for children
-
intensive multi-cellular agent based models (ABMs) of Epstein–Barr Virus (EBV) and HIV-1 infection dynamics in human lymphoid tissue. This postdoctoral associate will collaborate with experimentalists